Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
These criminals take advantage of victims before, during, and after a natural disaster strikes, targeting people when they ...
The conservative think tank has filed thousands of public-information requests, clogging the pipeline at federal agencies in ...
FTC began the process to unionize back in 2023, raising concerns about their access to telework, potential politicization of the civil service and other issues.
The Federal Trade Commission says a $48 million settlement should put an end to what it calls "predatory" tactics by the ...
Federal regulators have filed an administrative complaint against the St. Louis-based pharmacy benefit manager. Patients and ...
Ohio Attorney General Dave Yost and 11 other Republican attorneys general on Monday filed a brief in federal court in ...
The FTC is warning Ohioans that consumer scams are on the rise, and unfortunately, scammers are growing more sophisticated in laying their traps.
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
A federal judge has ruled that the Federal Trade Commission can proceed with its case that Amazon operates as an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback